Solutions · Healthcare
Discovery that needs no BAA, because no PHI leaves.
NexDiscovery is a Proactive Intelligence platform for health systems, payers, and pharma, built on autonomous cross-system discovery. It searches across clinical, scheduling, operations, and billing systems to surface cost-to-serve, operational, and data-quality signals, and it runs inside the organisation with read-only access, so protected health information is designed to stay inside your environment, reducing the scope of HIPAA Business Associate Agreement review. Whether a BAA is required depends on the specific engagement and access model.
No financial commitment at this stage
Runs entirely inside your environment. Nothing leaves.
The problem
The waste is real. The BAA negotiation is what delays the work.
Cost and quality cross systems
Cost-to-serve, scheduling friction, and data errors live across EHR, scheduling, operations, and billing systems that do not connect.
Every vendor needs a BAA
A HIPAA Business Associate Agreement is required when a vendor handles PHI, and that negotiation commonly takes 6 to 12 months before any work begins.
PHI sensitivity stalls AI
Most AI tools route data to an external model, which is a non-starter where PHI must never leave the environment.
What it finds
Operational and margin signals, without touching PHI externally.
Cost-to-serve outliers
Segments and pathways that consume disproportionate effort.
Operational friction
Scheduling, throughput, and rework that quietly add cost.
Data-quality risk
Inconsistent records that distort operational and financial decisions.
Revenue-cycle leakage
Where billing and reimbursement signals diverge across systems.
Utilization patterns
Capacity and demand mismatches visible only across systems.
Avoidable cost
Preventable spend identified by correlating operations and finance.
Terms used on this page: Action Pack. See the full glossary.
Proof
What the engine would surface in your environment.
An illustrative example of the output format. Real findings are delivered against your own data, traced to your own records, and approved before any figure is shared externally.
- What was found
- A segment of high cost-to-serve patient pathways consuming effort out of proportion to their volume, visible only when scheduling, operations, and billing were correlated.
- Estimated impact
- Material avoidable operating cost, identified, not guaranteed.
- Evidence
- Scheduling throughput, operational effort, and billing data, correlated across all three.
- Recommended action
- Redesign the pathway for the identified segment.
- Suggested owner
- Chief Operating Officer.
Illustrative example. Figures from real engagements are shared only with written client approval.
The angle that matters most
No PHI leaves, so no BAA is required.
A HIPAA Business Associate Agreement is required when a vendor handles protected health information. With NexDiscovery, the engine runs inside your infrastructure and no PHI is transmitted to us or to any external model, which is designed to remove the need for a BAA in most engagements. Your privacy office confirms the determination for your specific engagement. Removing that negotiation removes the 6 to 12 months it usually adds.
FAQ
Questions, answered.
Do you need a HIPAA BAA?
Does PHI go to an external model?
Can we scope it to non-clinical data first?
Start the work without starting a BAA.
No financial commitment at this stage
Runs entirely inside your environment. Nothing leaves.